Resección endometrial y sistema intrauterino de liberación de levonorgestrel en el tratamiento de la hemorragia uterina disfuncional

Article information

Resumen

Objetivos

Comparar la resección endometrial y el sistema intrauterino de liberación de levonorgestrel en el tratamiento de la hemorragia uterina disfuncional

Pacientes Y Método

Se incluye a 87 mujeres premenopáusicas con menorragia. La pérdida menstrual se estima mediante una tabla pictográfica y las determinaciones de hemoglobina y ferritina. Evaluamos el grado de satisfacción con el tratamiento

Resultados

A los 6 meses, 6 mujeres (18%) en el grupo del dispositivo y 4 mujeres (12%) en el grupo de resección presentaron menorragia recurrente. El grado de satisfacción fue elevado en ambos grupos

Conclusiones

El sistema intrauterino de levonorgestrel es un tratamiento no quirúrgico efectivo en la hemorragia uterina disfuncional. La resección endometrial es más efectiva, pero implica cirugía

Palabras clave:

Sistema intrauterino de levonorgestrel

Resección endometrial

Hemorragia uterina disfuncional

Histeroscopia

Summary

To compare endometrial resection versus the levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding

Patients And Methods

Eighty-seven premenopausal women with menorrhagia were included. Menstrual loss was estimated using a pictorial chart and serum hemoglobin and ferritin determinations. The degree of satisfaction with the treatment was evaluated

Results

Recurrent menorrhagia was observed at 6 months in six women (18%) in the intrauterine device group and in four women (12%) in the resection group. The degree of satisfaction was high in both groups

Conclusions

The levonorgestrel intrauterine system is an effective nonsurgical treatment of dysfunctional uterine bleeding. Endometrial resection is more effective but involves surgery

Keywords:

Levonorgestrel intrauterine system

Endometrial resection

Dysfunctional uterine bleeding

Hysteroscopy

Full text is only aviable in PDF

Bibliografía

[1.]

I.S. Fraser, G. McCarron, R. Markham.

A preliminary study of factors influencing perception of menstrual blood loss volume.

Am J Obstet Gynecol, 149 (1984), pp. 788-793

Medline

[2.]

L. Speroff, R.H. Glass, N.G. Kase.

Endocrinología ginecológica e infertilidad, 1.a ed, pp. 575-594

[3.]

M. Tahir, M.A. Bigrigg, J.J. Browning.

A randomised controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with inpatient hysteroscopy and curettage.

Br J Obstet Gynaecol, 106 (1999), pp. 1259-1264

Medline

[4.]

C. Wood.

The association of psycho-social factors and gynaecological symptoms.

Aust Fam Physician, 7 (1978), pp. 471-478

Medline

[5.]

J.M. Higham, P.M.S. O'Brien, R.W. Shaw.

Assessment of menstrual blood loss using a pictorial chart.

Br J Obstet Gynaecol, 97 (1990), pp. 734-739

Medline

[6.]

T. Maruo, J.B. Laoag-Fernandez, P. Pakarinen, H. Murakoshi, I.M. Spitz, E. Johansson.

Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium.

Hum Reprod, 16 (2001), pp. 2103-2108

Medline

[7.]

S.G. Silverberg, M. Haukkamaa, H. Arko, C.G. Nilson, T. Luukkainen.

Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine device.

Inter J Gynecol Pathol, 5 (1986), pp. 235-241

[8.]

J.K. Andersson, G. Rybo.

Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.

Br J Obstet Gynaecol, 97 (1990), pp. 690-694

Medline

[9.]

A. Stewart, C. Cummins, L. Gold, R. Jordan, W. Phillips.

The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review.

Br J Obstet Gynaecol, 108 (2001), pp. 74-86

[10.]

J.W. Barrington, P. Bowen-Simpkins.

The levonorgestrel intrauterine system in the management of menorrhagia.

Br J Obstet Gynaecol, 104 (1997), pp. 614-616

Medline

[11.]

T. Römer.

Prospective comparison study of levonorgestrel IUD versus Roller-Ball endometrial ablation in the management of refractory recurrent hypermenorrhea.

Eur J Obstet Gynecol Reprod Biol, 90 (2000), pp. 27-29

Medline

[12.]

P.G. Crosignani, P. Vercellini, P. Mosconi, S. Oldani, I. Cortesi, O. De Giorgi.

Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.

Obstet Gynecol, 90 (1997), pp. 257-263

http://dx.doi.org/10.1016/S0029-7844(97)00226-3 | Medline

[13.]

A. Lethaby, S. Shepperd, I. Cooke, C. Harquhar, The Cochrane database of systematic reviews.

Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.

The Cochrane Library, issue 1, (2000),

[14.]

I. Sivin, J. Stern, E. Coutinho, C.E.R. Mattos, S. El Mahgoub.

Díaz. Prolonged intrauterine contraception: a seven year randomized study of the levonorgestrel 20 μg/day (LNg 20) and the Copper T 380 Ag IUDs.

Contraception, 44 (1991), pp. 473-480

Medline

[15.]

K. Andersson, I. Batar, G. Rybo.

Return to fertility after removal of a levonorgestrel releasing intrauterine device and NOVA T.

Contraception, 45 (1992), pp. 575-584

[16.]

A.B. Copperman, A.H. De Cherney, D.L. Olive.

A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding.

Obstet Gynecol, 82 (1993), pp. 640-642

Medline

[17.]

W.S. Alford, M.P. Hopkins.

Endometrial roller-ball ablation.

J Reprod Med, 41 (1996), pp. 251-254

Medline

[18.]

L. Menscaglia.

Preparation of the endometrium prior to hysteroscopic surgery.

Eur J Obstet Gynecol Reprod Biol, 65 (1996), pp. 107-108

[19.]

A. Perino, P. Quartararo, E. Catinella, G. Genova, E. Cittadini.

Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.

Acta Eur Fertilitatis, 18 (1987), pp. 137-140

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter